Functional Genomics Market Demonstrates Long-Term Growth Potential At 14.1% CAGR

The field of functional genomics is set to undergo remarkable expansion in the coming years, driven by significant technological advancements and growing research investments. This emerging sector is rapidly evolving and holds promise for transforming medicine, agriculture, and biotechnology. Let's explore the current market size, key players, influential trends, and segmentation details shaping the future of functional genomics.

Forecasted Growth and Market Size of Functional Genomics
The functional genomics market is poised for swift growth, with its valuation expected to reach $28.71 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 14.1% during the forecast period. The surge is propelled by factors such as greater adoption of precision medicine techniques, increased funding for genomic data analytics, broadening applications of gene editing research, stronger collaborations between academic institutions and industry, and a growing emphasis on translational genomics studies. Key market trends involve the widespread use of high-throughput functional genomics tools, integration of multi-omics platforms, incorporation of artificial intelligence for gene function analysis, advancement of automated genomic workflows, and intensified investigations into disease mechanisms.

The functional genomics market size has grown rapidly in recent years. It will grow from $14.84 billion in 2025 to $16.96 billion in 2026 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to expansion of genomics research funding, increasing availability of sequencing technologies, growth in academic genomics research, rising demand for functional gene analysis, improvements in bioinformatics tools.

Download a free sample of the functional genomics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28228&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Prominent Players Leading Advances in the Functional Genomics Sector
The functional genomics landscape is shaped by several influential companies, including Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Becton dic*kinson and Company, Agilent Technologies Inc., Illumina Inc., Perkin Elmer Inc., Revvity Inc., Exact Sciences Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Integrated DNA Technologies Inc., Promega Corporation, Pacific Biosciences of California Inc., Genomics Ltd., MEDiC LLC, Enhanc3D Genomics Ltd., Samplix, Arima Genomics Inc., and Phase Genomics Inc.

Expansion through Strategic Acquisition in 2025
In January 2025, US-based biopharmaceutical firm Vividion Therapeutics Inc., known for its work in small-molecule drug discovery, acquired Tavros Therapeutics Inc., a biotechnology company specializing in genomic screening for target discovery. This acquisition enhances Vividion's functional genomics capabilities by combining Tavros's genomic screening platform with Vividion's chemoproteomics expertise. The partnership aims to accelerate identification of novel drug targets, particularly in oncology and immunology. Tavros Therapeutics is recognized for its innovative genomic screening technologies that enable precise target discovery.

View the full functional genomics market report:
https://www.thebusinessresearchcompany.com/report/functional-genomics-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Trends Highlighting Functional Genomics Innovations
Industry leaders in functional genomics are concentrating efforts on pioneering advanced methodologies like high-throughput sequencing to deliver in-depth, precise insights into complex genomes. High-throughput sequencing facilitates rapid and simultaneous analysis of vast quantities of DNA or RNA, providing broad-scale genetic information critical for research and clinical use.

A cutting-edge example of such innovation came in February 2025 when Roche, a pharmaceutical giant based in Switzerland, introduced its sequencing by expansion (SBX) technology. This new next-generation sequencing platform combines SBX chemistry with an advanced sensor module to enable ultra-fast, scalable sequencing adaptable to multiple applications. The technology uses a biochemical process to convert DNA or RNA sequences into a surrogate polymer known as an Xpandomer, which is fifty times longer than the original nucleic acid. This transformation produces strong, low-noise signals that allow for clear and reliable detection. Additionally, the use of a CMOS-based sensor with parallel processing capabilities helps achieve highly accurate single-molecule nanopore sequencing with remarkable speed and flexibility.

Detailed Market Segmentation and Forecasts in Functional Genomics
The global functional genomics market is categorized by several criteria:

1) Product Types: Kits and Assays, Instruments
2) Technology Platforms: Next-Generation Sequencing (NGS), Microarray Analysis, CRISPR and Gene Editing Technologies, RNA Sequencing (RNA-Seq)
3) End Users: Academic and Research Institutes, Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations (CROs), Clinical Laboratories, Agricultural Biotechnology Companies

Further subcategories break down as follows:

- Kits and Assays include PCR kits, microarray kits, NGS kits, reagents, and enzymes.
- Instruments encompass sequencers, microarray scanners, PCR instruments, and automation systems.

This segmentation offers a comprehensive view of the diverse functional genomics tools and technologies used across various sectors, aiding in the precise targeting of applications and users.

New strategic additions in our 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.